Liver damage profile in COVID-19 pregnant patients.

Bibliographic Details
Title: Liver damage profile in COVID-19 pregnant patients.
Authors: Januszewski, Marcin, Ziuzia-Januszewska, Laura, Kudan, Michal, Pluta, Kamil, KlapaczyƄski, Jakub, Wierzba, Waldemar, Maciejewski, Tomasz, Jakimiuk, Alicja A., Jakimiuk, Artur J.
Source: Cell Communication & Signaling; 1/2/2024, Vol. 22 Issue 1, p1-11, 11p
Subject Terms: COVID-19, GAMMA-glutamyltransferase, ASPARTATE aminotransferase, LIVER, BILE acids, LIVER function tests, PREGNANCY outcomes
Geographic Terms: WARSAW (Poland)
Abstract: Introduction: SARS-CoV-2 unsparingly impacts all areas of medicine. Pregnant women are particularly affected by the pandemic and COVID-19 related liver damage seems to be another threat to maternal and fetal health. The aim of this study is to define liver damage profile including bile acids serum levels in COVID-19 pregnant patients and to determine predictors of disease aggravation and poor obstetrics outcomes. Methods: This study has been carried out in the Obstetrics and Gynecology Department, at the National Medical Institute in Warsaw, Poland between 01.02.2021 and 01.11.2022 The study cohort comprises 148 pregnant patients with COVID-19 and 102 pregnant controls who has been tested negative for SARS-CoV-2. Results: COVID-19 pregnant patients presented liver involvement at admission in 41,9%. Hepatotoxic damage accounted for 27 (19.85%), cholestatic type was diagnosed in 11 (8.09%) and mixed type of liver injury was presented in 19 (13.97%) of patients. Higher serum levels of AST, ALT, GGT, total bilirubin and bile acids as well as mixed type of liver injury at admission were correlated with severe form of an illness. AST and ALT above upper reference limit as well as hepatotoxic type of liver damage predisposed pregnant patients with COVID-19 to poor obstetrics outcomes. Conclusion: Hepatic damage in pregnant women with COVID-19 is a common, mild, transaminase-dominant, or mixed type of injury, and often correlates with elevated inflammatory markers. SARS-CoV-2 test should be performed as a part of differential diagnosis in elevated liver function tests. Although bile acids serum levels were commonly elevated they seems to be clinically irrelevant in terms of pregnancy outcomes. DaRpyovs-oA9XgYzu_a_v9 Video Abstract [ABSTRACT FROM AUTHOR]
Copyright of Cell Communication & Signaling is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Full text is not displayed to guests.
More Details
ISSN:1478811X
DOI:10.1186/s12964-023-01285-z
Published in:Cell Communication & Signaling
Language:English